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Abstract
Osteopontin (SPP1) is an important bone matrix mediator found to have key roles in inflammation and immunity. SPP1
genetic polymorphisms and increased osteopontin protein levels have been reported to be associated with SLE in small
patient collections. The present study evaluates association between SPP1 polymorphisms and SLE in a large cohort of 1141
unrelated SLE patients [707 European-American (EA) and 434 African-American (AA)], and 2009 unrelated controls (1309 EA
and 700 AA). Population-based case-control association analyses were performed. To control for potential population
stratification, admixture adjusted logistic regression, genomic control (GC), structured association (STRAT), and principal
components analysis (PCA) were applied. Combined analysis of 2 ethnic groups, showed the minor allele of 2 SNPs
(rs1126616T and rs9138C) significantly associated with higher risk of SLE in males (P=0.0005, OR=1.73, 95% CI=1.28–2.33),
but not in females. Indeed, significant gene-gender interactions in the 2 SNPs, rs1126772 and rs9138, were detected
(P=0.001 and P=0.0006, respectively). Further, haplotype analysis identified rs1126616T-rs1126772A-rs9138C which
demonstrated significant association with SLE in general (P=0.02, OR=1.30, 95%CI 1.08–1.57), especially in males
(P=0.0003, OR=2.42, 95%CI 1.51–3.89). Subgroup analysis with single SNPs and haplotypes also identified a similar pattern
of gender-specific association in AA and EA. GC, STRAT, and PCA results within each group showed consistent associations.
Our data suggest SPP1 is associated with SLE, and this association is especially stronger in males. To our knowledge, this
report serves as the first association of a specific autosomal gene with human male lupus.
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Introduction
Systemic Lupus Erythematosus (SLE) is a prototypic human
autoimmune disease characterized by impaired T cell responses,
dysregulated B cell activation, hyperactive B cells and autoanti-
body production leading to inflammation and potential end-organ
damage. While the etiology of SLE remains complex, genetic
factors are known to be important in the pathogenesis of SLE
[1,2]. The current collection of genetic information suggests that
SLE susceptibility arises from specific combinations of multiple
gene-gene and gene-environment interactions. Among the genetic
factors believed to influence SLE susceptibility, the major
histocompatibility complex (MHC) alleles show the most signifi-
cant association, but these do not explain the total genetic
background of the disease. Importantly, several recent studies
show that non-HLA genes play a role in SLE development [3–7].
Recently, several lines of evidence suggest that secreted phospho-
protein 1 (SPP1) located at 4q22, also called osteopontin and early
T-lymphocyte activation 1, may have a role in the pathogenesis of
SLE as well as other autoimmune disorders.
SPP1 plays a key role in bone biology and has recently found to
also be important in regulating inflammation and immunity. The
immunologic functions of SPP1 include enhancing the proin-
flammatory Th1 cell response and inhibiting the Th2 responses
[8–9]. In addition, some studies have suggested that SPP1 plays a
role in the survival of activated T cells by inducing apoptosis, while
others have demonstrated the essential role of an intracellular form
of SPP1 in the production of interferon-alpha by plasmacytoid
dendritic cells [10,11]. Humans with SLE and autoimmune prone
mice over express osteopontin suggesting that abnormal expres-
sion of this protein may participate in SLE disease pathogenesis
[12,13]. Further, polymorphic osteopontin alleles have been
implicated in the development of a mouse model of lupus [14].
SNPs in the SPP1 gene have also been reported to be associated
with human SLE, adding further support to the role of this gene in
SLE pathogenesis [15]. A significant association between
rs11226616 and SLE was first demonstrated in a small North
American Caucasian cohort study [15]. Two SNPs (rs1126772
and rs9138) in the 39 UTR in the SPP1 gene were associated with
high levels of SPP1 and elevated risk of developing autoimmune/
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an autoimmune pattern similar to lupus prone strains of mice [16].
The same group later showed significant associations between SLE
and 2 SPP1 SNPs (rs7687316 and rs9138) in an Italian population
[17]. This information prompted us to test association between
SPP1 polymorphisms and SLE in a large, multi-ethnic collection.
Results
Marker information, minor allele frequency and the statistical
significance for allele distributions between cases and controls are
presented in Table 1. The only significant difference in allele
distribution was observed in the combined male-female group for
rs6840362, which showed a significant difference allele distribu-
tion in EA (P=0.015). However, significant differences were
evident in the male subgroup. This finding was especially strong in
EA males, where 3 SNPs (rs1126616, rs1126772 and rs9138)
showed significant differences in allele distributions. Similarly, in
AA males, 2 SNPs (rs1126616 and rs9138) demonstrated
significant differences in allele distribution.
We evaluated the association of each polymorphism with SLE,
adjusting for the admixture proportion utilizing logistic regression
under the multiplicative genetic model for minor alleles by
combined analysis. Considering the gender effect in allele
distributions and possible race specific effect in disease suscepti-
bility, subgroup analysis stratified by gender and race were also
performed. Table 2 shows the association results in detail. Briefly,
2 SNPs’ minor alleles (rs1126616T and rs9138C) showed
significant associations with SLE in AA and EA combined males,
but not in females, both of which conferred a high risk of SLE
(P=0.0005, OR=1.73, 95%CI 1.28–2.33). Indeed, significant
gene-gender interactions in the 2 SNPs, rs1126772 and rs9138,
were detected (P=0.001, P=0.0006, respectively). Subgroup
analysis by race revealed the same trend in AA and EA. For
AA, 3 SNPs (rs11728697, rs1126616, and rs9138) showed
significant association in males only (P=0.02, P=0.027,
P=0.027, respectively). In EA males, 3 SNPs (rs1126616,
rs1126772, and rs9138) also showed significant association
(P=0.003, P=0.028, P=0.003). Furthermore, to exclude the
false positive association which can arise from hidden population
substructure, we utilized GC, STRAT, and PCA to verify the
association result in each population. All associations remained
consistent with the admixture adjusted logistic regression analysis
(Table 3).
To assess the effect of any particular clinical feature on the
genetic association, we have performed a subgroup analysis
classified by eight clinical characteristics (Cutaneous manifesta-
tions, arthritis, serositis, renal involvement, neuro-psychiatric
manifestations, hematological features, anti-dsDNA, antinuclear
antibody) available for males (91 male SLE) and females (754
female SLE) separately. Although we did not find any significant
association in females, we did observed evidence of association in
males for some of the clinical features; however, these associations
are not stronger than the overall male-specific analysis. Therefore,
there seems to be no evidence that the overall effect is dominated
by a particular subset.
Haplotype analysis was performed to further evaluate the role of
SPP1 in SLE susceptibility. We conducted haplotype reconstruc-
tion and linkage disequilibrium analysis incorporating all 11 SNPs
in the SPP1 gene. The LD map and each SNP associated P value
are depicted in Fig. 1. Notably, rs1126616 and rs9138 are almost
in complete LD in both AA (Fig. 1A) and EA (Fig. 1B), which
explained their similar behavior in the association with SLE.
Initially, we included all selected 11 SNPs for haplotype analysis in
combined data and each race specific population adjusted by
admixture proportion. In accordance with the results of single
SNP analysis, no significant global association was detected either
in the combined analysis or in each specific population. The same
trend remained in the female subgroup. However, significant
haplotype association was observed in the male subgroup for the
combined, AA and EA (P=0.001, P=0.003, P=0.028, respec-
tively).
To further explore the haplotype effect in male subgroup, we
performed conditional analysis to detect if there was a specific SNP
or a subset of SNPs which can explain the global haplotype
association. Interestingly, the last 3 SNPs (rs1126616, rs1126772,
and rs9138) explained the whole association for each significant
group. When we performed haplotype association analysis
conditional on these 3 SNPs, all significant associations disappear
in the combined AA and EA subgroup. We next focused on these
3 SNPs for haplotype analysis. Detailed results are presented in
Table 4. Although single SNP analysis revealed only marginal
significant association, it is notable that in AA males the haplotype
analysis demonstrated a much stronger association (P=0.002).
Specifically, the haplotype TAC confers a high risk of SLE in AA
males (P=0.001, OR=3.37, 95%CI 1.65–6.92). In EA males, the
TAC haplotype is not significant, but there is a trend in the same
direction towards association with SLE (P=0.079, OR=1.84,
95%CI 0.96–3.53). Furthermore, in the combined male subgroup,
the haplotype TAC significantly increases the risk of SLE
(P=0.0004, OR=2.42, 95%CI 1.51–3.89). All the association
P-values were also verified by 10,000 permutations. Accordingly,
interaction analysis between haplotype and gender also showed
significant interactions in AA, EA, and the combined analysis
(P=0.018, P=0.02, P=0.0018, respectively).
Discussion
Our study confirms the previously reported genetic association
with SLE and presents additional support in a large multiethnic
cohort. Previous studies have suggested that increased SPP1
plasma concentration, as a result of increased gene/protein
expression and local production, was associated with SLE [13].
Therefore, SPP1 is a reasonable candidate gene for SLE
susceptibility. In the first report, Forton et al found that a silent
polymorphism (rs1126616) in exon 7 was significantly associated
with SLE [15]. Subsequently, 2 SNPs in the 59 (rs7687316) and 39
(rs9138) ends of the SPP1 gene were reported to contribute to SLE
susceptibility [16]. Although our combined male-female results
were marginally significant, associations with SLE were found for
haplotype analysis of 3 SNPs (rs1126616, rs1126772, and rs9138).
Since significant interactions were detected between gender and
the SPP1 SNPs, haplotypes were analyzed separately for males and
females. Our unique findings focus on stronger associations found
in male SLE patients from the combined analysis of samples from
2 different ethnic populations. Haplotype analyses revealed that
the last 3 SNPs in 39UTR explain the global association in males
and supports the hypothesis that the causal variant of SPP1 might
be near 39UTR, which could affect the expression level of SPP1.
SLE is at least nine times more prevalent in female compared to
male subjects; however, the underlying cause of the gender effect
has not been clearly established. There is evidence that gender-
specific genetic effects exist, both from the many differences in
animal models of lupus and from other previous work in humans
[18–21]. In a recent study by our group [22], a SLE linkage at
13q32 was identified and replicated by restricting the samples to a
relatively homogenous population of African-American families
containing at least one male affected. Therefore, taken all the
Gene-Gender Interaction in SLE
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courses and genetic predispositions in male lupus. Further study is
warranted to see if differences in osteopontin regulation are
involved in these differences.
Our haplotype analyses findings could also be significant due to
possible functionality of the three 39UTR SNPs. Recent years have
seen an increased appreciation for the importance of post-
transcriptional regulation in eukaryotic organisms [23]. The
untranslated region at the 39 end of a gene (39UTR) is involved
in regulating gene expression at both the pre-mRNA level and the
mature mRNA level. In the former, the 39UTR plays a central
role in mRNA 39 processing and polyadenylation, whereas in the
latter cis-elements in the 39UTR are bound by trans-acting factors
which modulate mRNA stability, nuclear export, subcellular
localization, and translation efficiency [24–27]. Micro-RNA target
sites in 39UTRs have been shown to be highly conserved [28].
Polymorphisms in microRNA target sites within the 39UTR may
influence gene expression in complex phenotypes, such as lupus
Table 1. Marker information and minor allele frequency in African-American and European-American sample.
African-American sample European-American sample
434/700
{ 707/1309
{
F: 403/475; M: 31/225
{ F: 617/936; M: 90/373
{
SNP Position Type Alleles STRATA Case Control Case Control
MA MAF MAF P* MA MAF MAF P*
rs2728127 89252294 59 near gene G/A All A 0.476 0.475 0.97 G 0.296 0.288 0.59
Female A 0.471 0.496 0.31 G 0.301 0.284 0.31
Male A 0.533 0.431 0.13 G 0.261 0.298 0.33
rs2853744 89253427 59 near gene G/T All T 0.252 0.240 0.52 T 0.060 0.058 0.79
Female T 0.252 0.240 0.57 T 0.061 0.060 0.88
Male T 0.258 0.241 0.77 T 0.050 0.052 0.90
rs11730582 89253600 59 near gene T/C All C 0.141 0.131 0.49 C 0.477 0.502 0.12
Female C 0.147 0.138 0.59 C 0.472 0.500 0.12
Male C 0.065 0.116 0.22 T 0.489 0.493 0.92
rs2853749 89254993 intron_0 C/T All T 0.393 0.393 0.98 T 0.294 0.289 0.71
Female T 0.392 0.387 0.84 T 0.299 0.285 0.38
Male T 0.403 0.406 0.96 T 0.261 0.299 0.32
rs11728697 89256120 intron_3 C/T All T 0.244 0.230 0.44 C 0.423 0.412 0.50
Female T 0.238 0.242 0.85 C 0.429 0.412 0.34
Male T 0.323 0.204 0.03 C 0.382 0.413 0.45
rs6840362 89257099 intron_3 C/T All T 0.354 0.337 0.42 T 0.258 0.295 0.01
Female T 0.354 0.330 0.29 T 0.259 0.285 0.11
Male T 0.355 0.353 0.98 T 0.256 0.322 0.08
rs6811536 89259584 intron_4 C/T All T 0.418 0.405 0.53 T 0.280 0.307 0.07
Female T 0.413 0.399 0.56 T 0.281 0.297 0.32
Male T 0.500 0.418 0.23 T 0.272 0.332 0.12
rs10516799 89260372 intron_5 G/C All C 0.344 0.328 0.44 C 0.279 0.308 0.05
Female C 0.346 0.324 0.32 C 0.279 0.298 0.26
Male C 0.317 0.338 0.74 C 0.272 0.332 0.12
rs1126616 89261032 exon_6 C/T All T 0.209 0.185 0.17 T 0.288 0.270 0.22
Female T 0.202 0.190 0.50 T 0.280 0.285 0.79
Male T 0.290 0.176 0.03 T 0.344 0.235 0.002
rs1126772 89261365 39 UTR A/G All G 0.053 0.061 0.45 G 0.220 0.218 0.86
Female G 0.056 0.061 0.65 G 0.214 0.229 0.31
Male G 0.016 0.060 0.15 G 0.267 0.190 0.02
rs9138 89261521 39 UTR A/C All C 0.205 0.184 0.23 C 0.286 0.271 0.31
Female C 0.198 0.188 0.60 C 0.277 0.285 0.64
Male C 0.290 0.176 0.03 C 0.344 0.235 0.002
MAF=minor allele frequency;
MA=minor allele;
*=chi-square test or Fisher exact test where appropriate, significant associations at the 0.05 significance level are bold.
{case/control number in all, male and female subgroup respectively.
doi:10.1371/journal.pone.0001757.t001
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antisense transcripts [30]. A search of the PolyA_DB2 database
shows that there is supporting cDNA/EST evidence for 2
transcripts with different polyadenylation sites in the SPP1 gene
[31]. In addition, the PolymiRTS (polymorphic microRNA Target
Site) database revealed evidence that suggests that SNP rs1126772,
which shows association with lupus in this report, is predicted to
disrupt a non-conserved microRNA target site [32]. Two 39UTR
SNPs, rs1126893, and rs2853754, which are not tested in the
present association study, are predicted to disrupt two evolution-
arily conserved microRNA target sites. Interestingly, the
rs1126893 is in complete LD and within the same haplotype
block with our associated SNPs (rs1126772 and rs9138 at the
39UTR) based on Hapmap data of CEPH families. In fact, the
distance between rs1126893 and rs2853754 is only 30 bp, the
alternative allele for SNP rs2853754 is predicted to create
microRNA target sites for 2 microRNAs. A more extensive
analysis of these potential mechanisms for the 39UTR control of
SPP1 gene expression will be required to determine if these
predicted sites may be responsible for this genetic association.
However, we acknowledge that the current study suffers from
some shortcomings. First, the samples size for the male SLE
patients is small (121 males); the association results in male
subgroup analysis might arise by chance. However, the possibility
of false positives arising from the multiple testing problems should
be small since the reported P value is significant enough to survive
even the most conservative Bonferroni correction. Second, none of
the previously published functional studies were performed to
Table 2. Associations of SNPs with SLE by logistic regression under multiplicative genetic model
SNP Strata AA samples EA samples Combined sample
P OR(95% CI) P OR(95% CI) P OR(95% CI)
rs2728127 All 0.72 0.97 (0.81–1.16) 0.59 1.04 (0.90–1.20) 0.56 1.03 (0.92–1.16)
Female 0.34 0.91 (0.75–1.10) 0.29 1.09 (0.93–1.28) 0.16 1.09 (0.97–1.23)
Male 0.10 1.56 (0.91–2.68) 0.35 0.84 (0.59–1.21) 0.10 0.78 (0.57–1.05)
rs2853744 All 0.61 1.05 (0.86–1.29) 0.9 1.02 (0.77–1.34) 0.65 1.04 (0.88–1.22)
Female 0.62 1.06 (0.85–1.32) 0.85 1.03 (0.77–1.38) 0.61 1.05 (0.88–1.25)
Male 0.98 1.01 (0.56–1.82) 0.92 0.96 (0.46–2.01) 0.90 1.03 (0.65–1.63)
rs11730582 All 0.63 1.07 (0.82–1.40) 0.17 0.91 (0.80–1.04) 0.35 0.95 (0.84–1.06)
Female 0.44 1.12 (0.84–1.48) 0.12 0.89 (0.77–1.03) 0.29 0.93 (0.82–1.06)
Male 0.35 0.62 (0.21–1.80) 0.99 1.00 (0.73–1.37) 0.78 0.96 (0.71–1.29)
rs2853749 All 0.92 1.01 (0.84–1.21) 0.69 1.03 (0.89–1.19) 0.72 1.02 (0.91–1.14)
Female 0.87 1.02 (0.84–1.23) 0.36 1.08 (0.92–1.26) 0.42 1.05 (0.93–1.19)
Male 0.87 0.96 (0.56–1.64) 0.33 0.84 (0.58–1.20) 0.39 0.88 (0.65–1.18)
rs11728697 All 0.44 1.09 (0.88–1.35) 0.57 1.04 (0.91–1.19) 0.97 1.00 (0.89–1.12)
Female 0.95 0.99 (0.79–1.25) 0.33 1.07 (0.93–1.24) 0.40 0.95 (0.84–1.07)
Male 0.02 2.03 (1.13–3.63) 0.53 0.90 (0.65–1.25) 0.10 1.28 (0.95–1.71)
rs6840362 All 0.33 1.10 (0.91–1.32) 0.03 0.85 (0.73–0.99) 0.30 0.94 (0.84–1.06)
Female 0.29 1.11 (0.91–1.36) 0.10 0.87 (0.74–1.03) 0.56 0.96 (0.85–1.09)
Male 0.86 0.95 (0.55–1.63) 0.06 0.70 (0.48–1.02) 0.15 0.80 (0.59–1.09)
rs6811536 All 0.37 1.09 (0.91–1.31) 0.12 0.89 (0.77–1.03) 0.52 0.96 (0.86–1.08)
Female 0.57 1.06 (0.87–1.28) 0.31 0.92 (0.78–1.08) 0.67 0.97 (0.86–1.10)
Male 0.31 1.33 (0.77–2.30) 0.09 0.73 (0.51–1.06) 0.49 0.90 (0.67–1.21)
rs10516799 All 0.41 1.08 (0.90–1.31) 0.09 0.88 (0.76–1.02) 0.43 0.96 (0.85–1.07)
Female 0.32 1.11 (0.91–1.35) 0.25 0.91 (0.78–1.07) 0.78 0.98 (0.87–1.11)
Male 0.68 0.89 (0.5–1.56) 0.09 0.73 (0.51–1.06) 0.14 0.80 (0.59–1.08)
rs1126616 All 0.16 1.18 (0.94–1.47) 0.34 1.07 (0.93–1.25) 0.13 1.10 (0.97–1.25)
Female 0.48 1.09 (0.86–1.39) 0.81 0.98 (0.83–1.15) 0.84 1.01 (0.89–1.16)
Male 0.027 2.01 (1.10–3.69) 0.003 1.71 (1.2–2.44) 0.0005 1.73 (1.28–2.33)
rs1126772 All 0.45 0.86 (0.59–1.27) 0.98 1.00 (0.85–1.17) 0.73 0.97 (0.84–1.13)
Female 0.70 0.93 (0.62–1.38) 0.30 0.91 (0.76–1.09) 0.27 0.91 (0.78–1.07)
Male 0.19 0.32 (0.04–2.44) 0.028 1.54 (1.05–2.26) 0.10 1.36 (0.95–1.95)
rs9138 All 0.20 1.16 (0.93–1.45) 0.44 1.06 (0.91–1.23) 0.19 1.09 (0.96–1.23)
Female 0.58 1.07 (0.84–1.36) 0.65 0.96 (0.82–1.13) 0.96 1.00 (0.87–1.14)
Male 0.027 2.01 (1.10–3.69) 0.003 1.71 (1.2–2.44) 0.0005 1.73 (1.28–2.33)
Significant associations at the 0.05 significance level are bold. For Combined sample, P value and OR were adjusted for admixture proportion and gender; for each
gender-specific sample, only admixture proportion was used as a covariate
doi:10.1371/journal.pone.0001757.t002
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this experiment is beyond the scope of the present study, we hope
to assess SPP1 gene and protein expression in male and female
lupus patients in future. It is worth noting that sex-specific
differences in SPP1 gene expression have been observed in rats
[33,34]. Third, an independent replication study should be
performed to further verify the male association. Like many other
association studies with complex phenotype, no matter how large,
validation in a second cohort is needed.
In summary, our data suggest the SPP1 gene might be
associated with the development of SLE in general and especially
in males. To our knowledge, this report serves as the first
description of a gender-specific human lupus genetic association.
Further in-depth molecular, genetic, and functional studies should
improve our understanding of the disease, and hopefully will
provide a more accurate diagnostic algorithm and improved
genetic counseling and management strategies.
Materials and Methods
Patients and controls
Genomic DNA samples from SLE patients and control subjects
were collected after obtaining written, informed consent from
1141 unrelated SLE patients [707 European-American (EA), 434
African-American (AA)], including 121 males (31 AA male
patients and 90 EA male patients), and 2009 unrelated controls
(1309 EA, 700 AA), including 598 males (225 AA male controls
and 373 EA male controls). Coded DNA samples were obtained
Table 3. Associations of SNPs with SLE by genomic control (GC), structured association test (STRAT), and principle components
analysis (PCA).
SNP Strata African-American sample European-American sample
GC STRAT PCA GC STRAT PCA
rs2728127 ALL 0.96 0.48 0.83 0.57 0.78 0.63
Female 0.31 0.67 0.31 0.29 0.18 0.38
Male 0.13 0.20 0.03 0.38 0.25 0.23
rs2853744 ALL 0.55 0.72 0.67 0.77 0.89 0.80
Female 0.55 0.65 0.25 0.85 0.93 0.91
Male 0.91 0.88 0.85 0.91 0.92 0.71
rs11730582 ALL 0.49 0.78 0.29 0.12 0.15 0.13
Female 0.60 0.59 0.59 0.11 0.06 0.20
Male 0.32 0.32 0.48 0.92 0.99 0.88
rs2853749 ALL 0.93 0.50 0.83 0.69 0.88 0.75
Female 0.83 0.66 0.73 0.36 0.22 0.43
Male 0.75 0.96 0.63 0.37 0.24 0.22
rs11728697 ALL 0.43 0.70 0.24 0.48 0.67 0.56
Female 0.83 0.79 0.79 0.33 0.44 0.49
Male 0.033 0.095 0.005 0.46 0.61 0.32
rs6840362 ALL 0.45 0.73 0.53 0.012 0.011 0.013
Female 0.30 0.57 0.65 0.11 0.07 0.12
Male 0.96 0.26 0.75 0.11 0.07 0.14
rs6811536 ALL 0.55 0.81 0.62 0.06 0.06 0.07
Female 0.58 0.77 0.29 0.31 0.41 0.36
Male 0.29 0.25 0.37 0.15 0.099 0.18
rs10516799 ALL 0.47 0.75 0.51 0.049 0.047 0.054
Female 0.34 0.66 0.56 0.25 0.34 0.30
Male 0.70 0.19 0.61 0.15 0.10 0.18
rs1126616 ALL 0.16 0.19 0.11 0.21 0.34 0.18
Female 0.51 0.82 0.31 0.81 0.87 1.00
Male 0.046 0.084 0.016 0.006 0.002 0.004
rs1126772 ALL 0.47 0.72 0.55 0.88 0.98 0.83
Female 0.65 0.89 0.62 0.29 0.30 0.48
Male 0.26 0.19 0.30 0.039 0.025 0.032
rs9138 ALL 0.22 0.25 0.15 0.29 0.47 0.26
Female 0.61 0.89 0.54 0.65 0.79 0.83
Male 0.046 0.079 0.016 0.006 0.002 0.004
Significant associations at the 0.05 significance level are bold.
doi:10.1371/journal.pone.0001757.t003
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lupus.omrf.org/). The study was approved by the Institutional
Review Boards (IRB) at the Oklahoma Medical Research
Foundation and University of Oklahoma Health Sciences Center.
All patients utilized in the study met SLE classification based upon
the revised criteria of the American College of Rheumatology
(ACR) [35].
Genotyping
Initially, we evaluated 32 SNPs in the SPP1 gene on the
Illumina SNP platform (San Diego, CA) at the University of Texas
Southwestern Microarray Core Facility (Dallas, TX) using
standard methods described in more detail (www.illumina.com).
A summary of the genotyping information for all the markers is
shown in supplementary Table S1. We included 11 SNPs in the
final analysis in which the controls in Hardy-Weinberg equilib-
rium, and a minor allele frequency of .1% in both the
populations. Marker information, genotype, and allele distribu-
tions of the 11 SNPs in cases and controls are summarized in
supplementary Table S2. Of the SNPs that failed quality control,
13 SNPs were monomorphic in 2 studied populations, 6 SNPs had
minor allele frequencies which were below 1% at least in one
population, 2 SNPs failed genotyping, and 1 SNP deviated
significantly from HWE in the black control group.
To know how much of the genetic variation of the SPP1 gene
that is captured by the 11 successfully genotyped SNPs, we
downloaded the tagged SNPs of SPP1 from the CEU population
from Hapmap database (http://www.hapmap.org) using Tagger
Pairwise method, in which MAF and LD (r-squared) cutoffs were
set to 0.05 and 0.8, respectively. We found 4 tagged SNPs,
rs6840362, rs9138, rs2853749, and rs11728697, which can
capture all other 10 genotyped SNPs by Hapmap project across
the gene. Actually, all these 4 tag SNPs were included in our
analyzed marker list. Therefore, all the known genetic variation of
the SPP1 gene should be captured by the 11 SNPs we analyzed,
especially for the European population.
Statistical analysis
Departures from Hardy–Weinberg equilibrium in cases and
controls were tested for SNPs with a Pearson Chi-square test.
Allele frequencies in SLE cases were compared to those in control
subjects using the Chi-square test or Fisher’s exact probability test,
where appropriate. Statistical evaluations for testing genetic effects
were performed using multivariate logistic regression analysis with
adjustments for gender and admixture proportions under
multiplicative genetic model. Interaction analysis was performed
by introducing the interaction term into the logistic regression
model including admixture proportion as a covariate. Statistical
significance was obtained by the likelihood ratio test comparing
the models with and without the interaction term. Haplotype-
based association analysis and conditional analysis were performed
by the WHAP program [36].
To control for possible confounding due to population
stratification, a panel of 221 ancestry informative markers (AIMs)
was genotyped using the same Illumina SNP platform for an
ongoing association study project in these LFRR samples.
Frequencies of the AIMS in the ancestry population European
and African are shown in supplementary Table S3. These AIMs
were selected based on the criteria of large allele frequency
differences (20% or greater allele frequency difference) between 2
ancestral populations, HWE in ancestral populations and all 221
AIMs were separated by al least 1 cM to minimize the possibility
of strong LD between AIMs. We used the STRUCTURE
program to estimate the admixture proportion for each individual
Figure 1. Linkage disequilibrium (LD) structure and association
P value in AA. LD is calculated from the genotype data in AA healthy
control population. Fig. 1B: LD structure and association P value in EA.
LD is calculated from the genotype data in EA healthy control
population.
doi:10.1371/journal.pone.0001757.g001
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varying number of population groups (k) was estimated from the
average of 3 independent runs (20,000 burn in and 30,000
iterations). As expected, the results favored a two-ancestry
population model in both AA and EA. The average proportion of
European ancestry was 0.17 in AA samples and 0.99 in EA samples.
We included the European ancestry proportion in eachindividual as
a covariate in the logistic regression model to control the population
stratification in subgroup and combined analysis. Additionally,
genomic control (GC) [38], structured association (STRAT) [39],
and principal components analysis (PCA) [40] were applied to
control for population stratification in race specific analysis.
Supporting Information
Table S1
Found at: doi:10.1371/journal.pone.0001757.s001 (0.02 MB
XLS)
Table S2
Found at: doi:10.1371/journal.pone.0001757.s002 (0.02 MB
XLS)
Table S3
Found at: doi:10.1371/journal.pone.0001757.s003 (0.05 MB
XLS)
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